Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
PSIX vs GNRC vs HLIO vs DCGO vs PESI
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Medical - Care Facilities
Waste Management
PSIX vs GNRC vs HLIO vs DCGO vs PESI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Medical - Care Facilities | Waste Management |
| Market Cap | $1.59B | $15.47B | $2.24B | $67M | $240M |
| Revenue (TTM) | $531M | $4.33B | $839M | $330M | $62M |
| Net Income (TTM) | $114M | $189M | $49M | $-182.40T | $-14M |
| Gross Margin | 34.8% | 38.1% | 32.3% | 30.7% | 9.6% |
| Operating Margin | 20.7% | 7.5% | 7.8% | -55.3% | -19.0% |
| Forward P/E | 14.5x | 30.6x | 26.8x | — | — |
| Total Debt | $152M | $1.33B | $111M | $29.18T | $4M |
| Cash & Equiv. | $41M | $341M | $73M | $52.48T | $12M |
PSIX vs GNRC vs HLIO vs DCGO vs PESI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Power Solutions Int… (PSIX) | 100 | 2257.3 | +2157.3% |
| Generac Holdings In… (GNRC) | 100 | 114.0 | +14.0% |
| Helios Technologies… (HLIO) | 100 | 128.4 | +28.4% |
| DocGo Inc. (DCGO) | 100 | 6.1 | -93.9% |
| Perma-Fix Environme… (PESI) | 100 | 197.3 | +97.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PSIX vs GNRC vs HLIO vs DCGO vs PESI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PSIX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 487.5% 10Y total return vs GNRC's 6.6%
- Better valuation composite
- 21.5% margin vs DCGO's -56.6%
- +148.3% vs DCGO's -70.9%
GNRC lags the leaders in this set but could rank higher in a more targeted comparison.
HLIO is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 1.56, yield 0.5%
- Lower volatility, beta 1.56, Low D/E 11.9%, current ratio 2.90x
- Beta 1.56, yield 0.5%, current ratio 2.90x
- Beta 1.56 vs PSIX's 3.33, lower leverage
DCGO ranks third and is worth considering specifically for growth exposure.
- Rev growth 523K%, EPS growth -11.2%, 3Y rev CAGR 89.1%
- 523K% revenue growth vs PSIX's -100.0%
Among these 5 stocks, PESI doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 523K% revenue growth vs PSIX's -100.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 21.5% margin vs DCGO's -56.6% | |
| Stability / Safety | Beta 1.56 vs PSIX's 3.33, lower leverage | |
| Dividends | 0.5% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +148.3% vs DCGO's -70.9% | |
| Efficiency (ROA) | 26.9% ROA vs DCGO's -336.1%, ROIC 36.9% vs -260.4% |
PSIX vs GNRC vs HLIO vs DCGO vs PESI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PSIX vs GNRC vs HLIO vs DCGO vs PESI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PSIX leads in 2 of 6 categories
DCGO leads 1 • HLIO leads 1 • GNRC leads 0 • PESI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — PSIX and HLIO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GNRC is the larger business by revenue, generating $4.3B annually — 70.1x PESI's $62M. PSIX is the more profitable business, keeping 21.5% of every revenue dollar as net income compared to DCGO's -56.6%. On growth, DCGO holds the edge at +999999.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $531M | $4.3B | $839M | $330M | $62M |
| EBITDAEarnings before interest/tax | $115M | $472M | $129M | -$174.09T | -$10M |
| Net IncomeAfter-tax profit | $114M | $189M | $49M | -$182.40T | -$14M |
| Free Cash FlowCash after capex | $4M | $419M | $103M | $19.47T | -$10M |
| Gross MarginGross profit ÷ Revenue | +34.8% | +38.1% | +32.3% | +30.7% | +9.6% |
| Operating MarginEBIT ÷ Revenue | +20.7% | +7.5% | +7.8% | -55.3% | -19.0% |
| Net MarginNet income ÷ Revenue | +21.5% | +4.4% | +5.8% | -56.6% | -22.3% |
| FCF MarginFCF ÷ Revenue | +0.8% | +9.7% | +12.3% | +6.0% | -16.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +12.4% | +17.4% | +999999.0% | +6.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -30.7% | +69.9% | +3.1% | -41.8% | -34.8% |
Valuation Metrics
DCGO leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 14.0x trailing earnings, PSIX trades at a 86% valuation discount to GNRC's 98.0x P/E. On an enterprise value basis, PSIX's 14.8x EV/EBITDA is more attractive than GNRC's 34.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $15.5B | $2.2B | $67M | $240M |
| Enterprise ValueMkt cap + debt − cash | $1.7B | $16.5B | $2.3B | -$23.31T | $232M |
| Trailing P/EPrice ÷ TTM EPS | 13.99x | 98.02x | 46.76x | -0.37x | -17.24x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.50x | 30.55x | 26.85x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.74x | — | — |
| EV / EBITDAEnterprise value multiple | 14.80x | 34.01x | 17.69x | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 3.68x | 2.67x | 0.00x | 3.89x |
| Price / BookPrice ÷ Book value/share | 8.92x | 5.92x | 2.42x | 0.00x | 4.76x |
| Price / FCFMarket cap ÷ FCF | 112.58x | 57.70x | 21.66x | 0.00x | — |
Profitability & Efficiency
PSIX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PSIX delivers a 81.3% return on equity — every $100 of shareholder capital generates $81 in annual profit, vs $-6 for DCGO. PESI carries lower financial leverage with a 0.09x debt-to-equity ratio, signaling a more conservative balance sheet compared to PSIX's 0.85x. On the Piotroski fundamental quality scale (0–9), HLIO scores 9/9 vs DCGO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +81.3% | +7.2% | +5.3% | -5.8% | -24.9% |
| ROA (TTM)Return on assets | +26.9% | +3.4% | +3.1% | -3.4% | -15.2% |
| ROICReturn on invested capital | +36.9% | +5.9% | +4.4% | -2.6% | -21.7% |
| ROCEReturn on capital employed | +50.7% | +6.9% | +4.8% | -2.4% | -16.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.85x | 0.51x | 0.12x | 0.23x | 0.09x |
| Net DebtTotal debt minus cash | $111M | $992M | $38M | -$23.31T | -$7M |
| Cash & Equiv.Liquid assets | $41M | $341M | $73M | $52.48T | $12M |
| Total DebtShort + long-term debt | $152M | $1.3B | $111M | $29.18T | $4M |
| Interest CoverageEBIT ÷ Interest expense | 13.09x | 4.54x | 3.84x | — | -26.91x |
Total Returns (Dividends Reinvested)
PSIX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PSIX five years ago would be worth $112,342 today (with dividends reinvested), compared to $686 for DCGO. Over the past 12 months, PSIX leads with a +148.3% total return vs DCGO's -70.9%. The 3-year compound annual growth rate (CAGR) favors PSIX at 186.1% vs DCGO's -56.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.3% | +86.9% | +24.3% | -23.0% | +5.6% |
| 1-Year ReturnPast 12 months | +148.3% | +126.1% | +145.8% | -70.9% | +44.1% |
| 3-Year ReturnCumulative with dividends | +2242.0% | +130.9% | +11.3% | -91.9% | +45.3% |
| 5-Year ReturnCumulative with dividends | +1023.4% | -17.4% | -6.2% | -93.1% | +75.0% |
| 10-Year ReturnCumulative with dividends | +487.5% | +660.8% | +110.5% | -93.4% | +248.5% |
| CAGR (3Y)Annualised 3-year return | +186.1% | +32.2% | +3.6% | -56.7% | +13.3% |
Risk & Volatility
Evenly matched — GNRC and HLIO each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLIO is the less volatile stock with a 1.56 beta — it tends to amplify market swings less than PSIX's 3.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GNRC currently trades 98.6% from its 52-week high vs DCGO's 27.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.33x | 1.69x | 1.56x | 2.27x | 1.85x |
| 52-Week HighHighest price in past year | $121.78 | $267.32 | $76.47 | $2.45 | $16.50 |
| 52-Week LowLowest price in past year | $25.09 | $113.50 | $27.12 | $0.49 | $8.02 |
| % of 52W HighCurrent price vs 52-week peak | +56.7% | +98.6% | +88.7% | +27.9% | +78.4% |
| RSI (14)Momentum oscillator 0–100 | 45.4 | 74.5 | 43.0 | 52.4 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 621K | 911K | 352K | 1.1M | 157K |
Analyst Outlook
HLIO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: PSIX as "Buy", GNRC as "Buy", HLIO as "Buy", PESI as "Hold". Consensus price targets imply 50.9% upside for PSIX (target: $104) vs 2.9% for GNRC (target: $271). HLIO is the only dividend payer here at 0.53% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — | Hold |
| Price TargetConsensus 12-month target | $104.26 | $271.22 | $77.00 | — | $18.00 |
| # AnalystsCovering analysts | 6 | 39 | 12 | — | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +0.5% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 1 | 1 | 1 |
| Dividend / ShareAnnual DPS | — | $0.00 | $0.36 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.0% | +0.6% | 0.0% | 0.0% |
PSIX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). DCGO leads in 1 (Valuation Metrics). 2 tied.
PSIX vs GNRC vs HLIO vs DCGO vs PESI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PSIX or GNRC or HLIO or DCGO or PESI a better buy right now?
For growth investors, DocGo Inc.
(DCGO) is the stronger pick with 522574% revenue growth year-over-year, versus -100. 0% for Power Solutions International, Inc. (PSIX). Power Solutions International, Inc. (PSIX) offers the better valuation at 14. 0x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate Power Solutions International, Inc. (PSIX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PSIX or GNRC or HLIO or DCGO or PESI?
On trailing P/E, Power Solutions International, Inc.
(PSIX) is the cheapest at 14. 0x versus Generac Holdings Inc. at 98. 0x. On forward P/E, Power Solutions International, Inc. is actually cheaper at 14. 5x.
03Which is the better long-term investment — PSIX or GNRC or HLIO or DCGO or PESI?
Over the past 5 years, Power Solutions International, Inc.
(PSIX) delivered a total return of +1023%, compared to -93. 1% for DocGo Inc. (DCGO). Over 10 years, the gap is even starker: GNRC returned +660. 8% versus DCGO's -93. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PSIX or GNRC or HLIO or DCGO or PESI?
By beta (market sensitivity over 5 years), Helios Technologies, Inc.
(HLIO) is the lower-risk stock at 1. 56β versus Power Solutions International, Inc. 's 3. 33β — meaning PSIX is approximately 114% more volatile than HLIO relative to the S&P 500. On balance sheet safety, Perma-Fix Environmental Services, Inc. (PESI) carries a lower debt/equity ratio of 9% versus 85% for Power Solutions International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PSIX or GNRC or HLIO or DCGO or PESI?
By revenue growth (latest reported year), DocGo Inc.
(DCGO) is pulling ahead at 522574% versus -100. 0% for Power Solutions International, Inc. (PSIX). On earnings-per-share growth, the picture is similar: Power Solutions International, Inc. grew EPS 64. 1% year-over-year, compared to -1122. 2% for DocGo Inc.. Over a 3-year CAGR, DCGO leads at 89. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PSIX or GNRC or HLIO or DCGO or PESI?
Power Solutions International, Inc.
(PSIX) is the more profitable company, earning 21. 5% net margin versus -56. 6% for DocGo Inc. — meaning it keeps 21. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PSIX leads at 20. 7% versus -55. 3% for DCGO. At the gross margin level — before operating expenses — GNRC leads at 38. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PSIX or GNRC or HLIO or DCGO or PESI more undervalued right now?
On forward earnings alone, Power Solutions International, Inc.
(PSIX) trades at 14. 5x forward P/E versus 30. 6x for Generac Holdings Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PSIX: 50. 9% to $104. 26.
08Which pays a better dividend — PSIX or GNRC or HLIO or DCGO or PESI?
In this comparison, HLIO (0.
5% yield) pays a dividend. PSIX, GNRC, DCGO, PESI do not pay a meaningful dividend and should not be held primarily for income.
09Is PSIX or GNRC or HLIO or DCGO or PESI better for a retirement portfolio?
For long-horizon retirement investors, Helios Technologies, Inc.
(HLIO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 5% yield, +110. 5% 10Y return). DocGo Inc. (DCGO) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLIO: +110. 5%, DCGO: -93. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PSIX and GNRC and HLIO and DCGO and PESI?
These companies operate in different sectors (PSIX (Industrials) and GNRC (Industrials) and HLIO (Industrials) and DCGO (Healthcare) and PESI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PSIX is a small-cap deep-value stock; GNRC is a mid-cap quality compounder stock; HLIO is a small-cap quality compounder stock; DCGO is a small-cap high-growth stock; PESI is a small-cap quality compounder stock. HLIO pays a dividend while PSIX, GNRC, DCGO, PESI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.